Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

Journal of Experimental Medicine

Volumn 207, Issue 6, 2010, Pages 1273-1281

  Bachem, Annabell ^a   Güttler, Steffen ^a   Hartung, Evelyn ^a   Ebstein, Frédéric ^b   Schaefer, Michael ^c   Tannert, Astrid ^c   Salama, Abdulgabar ^b   Movassaghi, Kamran ^b   Opitz, Corinna ^a   Mages, Hans W ^a   Henn, Volker ^a   Kloetzel, Peter Michael ^b   Gurka, Stephanie ^a   Kroczek, Richard A ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Rudolf Boehm Institute of Pharmacology and Toxicology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CALCIUM ION; CD141 ANTIGEN; CD16 ANTIGEN; CD1C ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CYTOMEGALOVIRUS ANTIGEN PP65; GLYCOPROTEIN P 15095; LYMPHOTACTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL MIGRATION; CELL SELECTION; CELL SUBPOPULATION; CHEMOTAXIS; CONTROLLED STUDY; CROSS PRESENTATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELOID DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11C; CALCIUM SIGNALING; CD8-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS; CROSS-PRIMING; DENDRITIC CELLS; HUMANS; MICE; MODELS, IMMUNOLOGICAL; PHOSPHOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, IGG; SOLUBILITY; THROMBOMODULIN; VIRAL MATRIX PROTEINS;

EID: 77953522371     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100348     Document Type: Article

References (36)

1. Andrews, D.M., E. Maraskovsky, and M.J. Smyth. 2008. Cancer vaccines for established cancer: how to make them better? Immunol. Rev. 222:242-255. doi:10.1111/j.1600-065X.2008.00612.x
2. Bevan, M.J. 2006. Cross-priming. Nat. Immunol. 7:363-365. doi:10.1038/ni0406-363
3. Caminschi, I., A.I. Proietto, F. Ahmet, S. Kitsoulis, J. Shin Teh, J.C. Lo, A. Rizzitelli, L. Wu, D. Vremec, S.L. van Dommelen, et al. 2008. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood. 112:3264-3273. doi:10.1182/blood-2008-05-155176
4. Caminschi, I., M.H. Lahoud, and K. Shortman. 2009. Enhancing immune responses by targeting antigen to DC. Eur. J. Immunol. 39:931-938. doi:10.1002/eji.200839035
5. Colonna, M., G. Trinchieri, and Y.J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5:1219-1226. doi:10.1038/ni1141
6. - dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:1685-1696. doi:10.1084/jem.192.12.1685
7. Di Pucchio, T., B. Chatterjee, A. Smed-Sörensen, S. Clayton, A. Palazzo, M. Montes, Y. Xue, I. Mellman, J. Banchereau, and J.E. Connolly. 2008. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. Immunol. 9:551-557. doi:10.1038/ni.1602 (Pubitemid 351560524)
8. Dorner, B.G., A. Scheffold, M.S. Rolph, M.B. Hüser, S.H. Kaufmann, A. Radbruch, I.E. Flesch, and R.A. Kroczek. 2002. MIP-1α, MIP-1β, RANTES, and ATAC/lymphotactin function together with IFN-γ as type 1 cytokines. Proc. Natl. Acad. Sci. USA. 99:6181-6186. doi:10.1073/pnas.092141999
9. + T cells. Immunity. 31:823-833. doi:10.1016/j.immuni.2009.08.027
10. Dzionek, A., A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S. Miltenyi, D.W. Buck, and J. Schmitz. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165:6037-6046.
11. Esmon, N.L., W.G. Owen, and C.T. Esmon. 1982. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J. Biol. Chem. 257:859-864.
12. Flavell, D.J., S.U. Flavell, D.A. Boehm, L. Emery, A. Noss, N.R. Ling, P.R. Richardson, D. Hardie, and D.H. Wright. 1995. Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours. Br. J. Cancer. 72:1373-1379.
13. + T-cell clones using peptide pulsed mature dendritic cells. J. Immunol. Methods. 258:111-126. doi:10.1016/S0022-1759(01)00477-X
14. Fonteneau, J.F., D.G. Kavanagh, M. Lirvall, C. Sanders, T.L. Cover, N. Bhardwaj, and M. Larsson. 2003. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood. 102:4448-4455. doi:10.1182/blood-2003-06-1801
15. Galibert, L., G.S. Diemer, Z. Liu, R.S. Johnson, J.L. Smith, T. Walzer, M.R. Comeau, C.T. Rauch, M.F. Wolfson, R.A. Sorensen, et al. 2005. Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J. Biol. Chem. 280:21955-21964. doi:10.1074/jbc.M502095200
16. Heath, W.R., and F.R. Carbone. 2009. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10:1237-1244. doi:10.1038/ni.1822
17. Heath, W.R., G.T. Belz, G.M. Behrens, C.M. Smith, S.P. Forehan, I.A. Parish, G.M. Davey, N.S. Wilson, F.R. Carbone, and J.A. Villadangos. 2004. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199:9-26. doi:10.1111/j.0105-2896.2004.00142.x (Pubitemid 38736761)
18. Hoeffel, G., A.C. Ripoche, D. Matheoud, M. Nascimbeni, N. Escriou, P. Lebon, F. Heshmati, J.G. Guillet, M. Gannagé, S. Caillat-Zucman, et al. 2007. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity. 27:481-492. doi:10.1016/j.immuni.2007.07.021
19. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195:1289-1302. doi:10.1084/jem.20020161
20. Ju, X., G. Clark, and D.N.J. Hart. 2010. Review of human DC subtypes. Methods Mol. Biol. 595:3-20. doi:10.1007/978-1-60761-421-0-1
21. 2+-controlled competitive diacylglycerol binding of protein kinase C isoenzymes in living cells. J. Cell Biol. 159:291-302. doi:10.1083/jcb. 200203048
22. Lin, M.L., Y. Zhan, J.A. Villadangos, and A.M. Lew. 2008. The cell biology of cross-presentation and the role of dendritic cell subsets. Immunol. Cell Biol. 86:353-362. doi:10.1038/icb.2008.3 (Pubitemid 351667998)
23. Lindstedt, M., K. Lundberg, and C.A. Borrebaeck. 2005. Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. J. Immunol. 175:4839-4846. (Pubitemid 41456365)
24. Liu, Y.J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23:275-306.
25. MacDonald, K.P., D.J. Munster, G.J. Clark, A. Dzionek, J. Schmitz, and D.N. Hart. 2002. Characterization of human blood dendritic cell subsets. Blood. 100:4512-4520. doi:10.1182/blood-2001-11-0097
26. Piccioli, D., S. Tavarini, E. Borgogni, V. Steri, S. Nuti, C. Sammicheli, M. Bardelli, D. Montagna, F. Locatelli, and A. Wack. 2007. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood. 109:5371-5379. doi:10.1182/blood-2006-08-038422
27. Robbins, S.H., T. Walzer, D. Dembélé, C. Thibault, A. Defays, G. Bessou, H. Xu, E. Vivier, M. Sellars, P. Pierre, et al. 2008. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 9:R17. doi:10.1186/gb-2008-9-1-r17
28. Robinson, S.P., S. Patterson, N. English, D. Davies, S.C. Knight, and C.D. Reid. 1999. Human peripheral blood contains two distinct lineages of dendritic cells. Eur. J. Immunol. 29:2769-2778. doi:10.1002/ (SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>.0.CO;2-2
29. Schnurr, M., Q. Chen, A. Shin, W. Chen, T. Toy, C. Jenderek, S. Green, L. Miloradovic, D. Drane, I.D. Davis, et al. 2005. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Blood. 105:2465-2472. doi:10.1182/blood-2004-08-3105
30. + dendritic cells is attributable to their ability to internalize dead cells. Immunology. 107:183-189. doi:10.1046/j.1365-2567.2002.01513.x
31. Segura, E., and J.A. Villadangos. 2009. Antigen presentation by dendritic cells in vivo. Curr. Opin. Immunol. 21:105-110. doi:10.1016/j.coi.2009.03.011
32. Shen, L., and K.L. Rock. 2006. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr. Opin. Immunol. 18:85-91. doi:10.1016/j.coi.2005.11.003
33. + dendritic cell subset. Immunol. Rev. 234:18-31. doi:10.1111/j.0105-2896.2009.00870.x
34. Steinman, R.M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature. 449:419-426. doi:10.1038/nature06175
35. Villadangos, J.A., and L. Young. 2008. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity. 29:352-361. doi:10.1016/j.immuni.2008. 09.002
36. Villadangos, J.A., W.R. Heath, and F.R. Carbone. 2007. Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells. Trends Immunol. 28:45-47. doi:10.1016/j.it.2006.12.008